PATENT CLAIM ANALYSIS

Application Number: 16063370
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["514", "339000"]

Abstract:
The present invention covers heteroarylbenzimidazole compounds of general formula (I) in which R 1 , R 2 , R 3 , R 4  and R 5  are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative and/or inflammatory disorders, as a sole agent or in combination with other active ingredients.

Claim (Index 17):
A compound of general formula (XL): in which R 1 , R 3 , R 4 , R 5  and R 9  are as defined for the compound of general formula (I) according to  claim 1 , and in which \u201c#\u201d indicates that the piperazine ring can be either unsubstituted or bridged, or substituted with one or two methyl groups, according to the definition of R 2  in general formula (I).

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.61404
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15080068', '14772865', '14403151', '13078192', '15083503']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7983735218367929
- 35 USC 102 Novelty (BERT): 0.5198261997183483
- Combined Prediction Score: 0.7705187896249485
- Mean Citation Score: 306.67584
- Max Citation Score: 309.4958200000001
- Similarity Product: 222.92228153136853

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test